🇺🇸 Prostaglandin E2 in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 20
Most-reported reactions
- Blood Pressure Increased — 2 reports (10%)
- Drug Exposure During Pregnancy — 2 reports (10%)
- Foetal Heart Rate Decreased — 2 reports (10%)
- Hyperkalaemia — 2 reports (10%)
- Malaise — 2 reports (10%)
- Maternal Exposure During Pregnancy — 2 reports (10%)
- Palpitations — 2 reports (10%)
- Paralysis Flaccid — 2 reports (10%)
- Platelet Count Decreased — 2 reports (10%)
- Respiratory Failure — 2 reports (10%)
Frequently asked questions
Is Prostaglandin E2 approved in United States?
Prostaglandin E2 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Prostaglandin E2 in United States?
Shaare Zedek Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.